Gynecologic cancer clinical trial eligibility criteria as a marker for equitable clinical trial access
Some, but not all, of the known restrictive comorbidity-based exclusion criteria have increased in gynecologic cancer clinical trial design, despite calls for improving racial and ethnic minority representation. Exclusion criteria are critical for trial safety, however, they must be carefully considered given the differential racial impact on eligibility.
Authors
- Heidi J. Gray (ORCID: https://orcid.org/0000-0002-3927-6739)
- Barbara A. Goff (ORCID: https://orcid.org/0000-0003-0153-5544)
- Ann Oluloro (ORCID: https://orcid.org/0000-0003-4944-7025)
- Kemi M. Doll (ORCID: https://orcid.org/0000-0002-3040-2962)
- Elizabeth M. Swisher (ORCID: https://orcid.org/0000-0003-2331-0434)
Institutions
- University of Washington (US)
Publication Details
- Journal
- JNCI Journal of the National Cancer Institute
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1093/jnci/djae338
- Citations
- 2
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 2.26
Funders
- National Cancer Institute